increased B cell derived lymphoma incidence_Flt3<tm2.1Dosm>/Flt3<+>

http://metadb.riken.jp/0002023B6129CFlt3tm21DosmFlt3tm21DosmFlt3Flt3tm21DosmFlt3

increased B cell derived lymphoma incidence_Flt3<tm2.1Dosm>/Flt3<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• FMS-like tyrosine kinase 3
  http://metadb.riken.jp/db/mgi_rdf/MGI:95559

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Flt3<tm2.1Dosm>/Flt3<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Flt3<tm2.1Dosm>|Flt3<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6.129(C)-Flt3<tm2.1Dosm>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased B cell derived lymphoma incidence
  http://purl.obolibrary.org/obo/MP_0002023

文献

http://purl.org/net/cito/citesAsAuthority

• Emily. Bailey, et.al., FLT3/D835Y mutation knock-in mice display less aggressive disease compared with FLT3/internal tandem duplication (ITD) mice., Proceedings of the National Academy of Sciences of the United States of America, 2013, 110
  http://rdf.ncbi.nlm.nih.gov/pubmed/24255108